UFP TECHNOLOGIES INC

UFP TECHNOLOGIES INCUFPTEarnings & Financial Report

Nasdaq · Health Care · Surgical & Medical Instruments & Apparatus

UFP Technologies, Inc. is an American multinational developer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products.

Revenue

$110.2M

Gross Profit

$33.0M

Operating Profit

$18.0M

Net Profit

$13.6M

Gross Margin

30.0%

Operating Margin

16.3%

Net Margin

12.3%

YoY Growth

10.1%

EPS

$1.75

UFP TECHNOLOGIES INC Q2 FY2024 Financial Summary

UFP TECHNOLOGIES INC reported revenue of $110.2M (up 10.1% YoY) for Q2 FY2024, with a net profit of $13.6M (up 14.0% YoY) (12.3% margin). Cost of goods sold was $77.1M, operating expenses totaled $15.1M.

Key Financial Metrics

Total Revenue$110.2M
Net Profit$13.6M
Gross Margin30.0%
Operating Margin16.3%
Report PeriodQ2 FY2024

Revenue Breakdown

UFP TECHNOLOGIES INC Q2 FY2024 revenue of $110.2M breaks down across 5 segments, led by Medical at $95.4M (86.6% of total).

SegmentRevenue% of Total
Medical$95.4M86.6%
Aerospace Defense$5.8M5.3%
Industrial Or Other$5.0M4.5%
Tooling And Machinery$3.3M3.0%
Engineering And Development$1.6M1.5%

UFP TECHNOLOGIES INC Revenue by Segment — Quarterly Trend

UFP TECHNOLOGIES INC revenue by segment across the last 4 reported quarters, showing how each business line (such as Medical and Aerospace Defense) has evolved quarter over quarter.

SegmentQ4 FY2025Q3 FY2025Q2 FY2025Q1 FY2025
Tooling And Machinery$1.5M
Engineering And Development$1.8M$1.5M$1.6M

UFP TECHNOLOGIES INC Annual Revenue by Year

UFP TECHNOLOGIES INC annual revenue history includes year-by-year totals (for example, 2025 revenue was $602.8M).

YearAnnual Revenue
2025$602.8M
2024$504.4M
2023$400.1M
2022$353.8M

UFP TECHNOLOGIES INC Quarterly Revenue & Net Profit History

UFP TECHNOLOGIES INC results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.

QuarterRevenueRevenue YoYNet ProfitNet Margin
Q4 FY2025$148.9M+3.4%$17.6M11.8%
Q3 FY2025$154.6M+6.5%$16.4M10.6%
Q2 FY2025$151.2M+37.2%$17.2M11.4%
Q1 FY2025$148.1M+41.1%$17.2M11.6%
Q4 FY2024$144.1M+41.9%$16.4M11.4%
Q3 FY2024$145.2M+44.0%$16.4M11.3%
Q2 FY2024$110.2M+10.1%$13.6M12.3%
Q1 FY2024$105.0M+7.4%$12.7M12.1%

Income Statement

Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
Revenue$105.0M$110.2M$145.2M$144.1M$148.1M$151.2M$154.6M$148.9M
YoY Growth7.4%10.1%44.0%41.9%41.1%37.2%6.5%3.4%

Balance Sheet

Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
Assets$407.7M$422.4M$638.5M$629.0M$642.6M$634.7M$652.8M$655.1M
Liabilities$112.7M$112.2M$309.4M$286.2M$282.0M$249.2M$248.9M$231.2M
Equity$295.0M$310.2M$329.1M$342.8M$360.7M$385.5M$403.9M$423.9M

Cash Flow

Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
Operating CF$10.7M$11.7M$19.8M$24.4M$13.8M$25.3M$35.9M$16.8M